CASI Pharmaceuticals
CASI
#10192
Rank
A$26.64 M
Marketcap
A$1.30
Share price
-7.70%
Change (1 day)
-73.45%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$67.77 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$31.56 Million. In 2024 the company made an earning of -A$57.21 Million a decrease over its 2023 earnings that were of -A$39.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$67.77 Million18.45%
2024 -A$57.21 Million44.35%
2023 -A$39.63 Million-29.55%
2022 -A$56.25 Million4.43%
2021 -A$53.86 Million-24.56%
2020 -A$71.4 Million4.74%
2019 -A$68.17 Million65.13%
2018 -A$41.29 Million155.07%
2017 -A$16.19 Million13.93%
2016 -A$14.21 Million31.18%
2015 -A$10.83 Million-72.5%
2014 -A$39.38 Million356.62%
2013 -A$8.63 Million-60.55%
2012 -A$21.86 Million218.41%
2011 -A$6.87 Million0.74%
2010 -A$6.82 Million-32.54%
2009 -A$10.11 Million-66.98%
2008 -A$30.59 Million-14.22%
2007 -A$35.66 Million7.04%
2006 -A$33.32 Million27.95%
2005 -A$26.04 Million4.51%
2004 -A$24.92 Million-15.84%
2003 -A$29.61 Million-55.29%
2002 -A$66.22 Million-34.05%
2001 -A$0.11 Billion31.73%
2000 -A$76.22 Million31.56%
1999 -A$57.94 Million145.56%
1998 -A$23.6 Million76.4%
1997 -A$13.38 Million36.92%
1996 -A$9.77 Million